Vue transversale globale
Toutes les maladies
Un même point d’entrée pour les études cliniques, les découvertes scientifiques, les publications et les pistes exploratoires présentes dans Biomedical Watch.
Périmètre
Filtrer toute la vue
Chaque choix s’applique immédiatement aux quatre sections. Le filtre « type de SEP » n’apparaît que lorsque la sclérose en plaques est sélectionnée.
10934 résultats correspondants
· 41 visibles sur cette page
dans le périmètre Toutes les maladies
Niveau clinique
Études et traitements 6003
Interventions, programmes et essais cliniques rattachés au périmètre sélectionné.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Pembrolizumab NCT03615326 · Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Grow… | Maladie de Parkinson | À vérifier | Phase 3 | COMPLETED | The purpose of this study was to evaluate the efficacy and safety of pembr… Dispositif/procédure : résultats à interpréter par essai et indication. | ClinicalTrials.gov 2026-08-26 14:49:14 | Détail |
| Active transcranial direct current stimulation NCT06554067 · Effects of tDCS and VNS on Postoperative Analgesia | Sclérose en plaques | Traitement symptomatique | Non applicable | NOT_YET_RECRUITING | This study seeks to evaluate the efficacy of transcranial direct current s… À vérifier | ClinicalTrials.gov 2026-08-26 14:49:11 | Détail |
| sham stimulation NCT04437498 · VNS mTBI — Vagal Nerve Stimulation in mTBI | Sclérose en plaques | À vérifier | Non applicable | RECRUITING | Attaining goals or rewards commonly entails response costs. In light of co… À vérifier | ClinicalTrials.gov 2026-08-26 14:49:11 | Détail |
| Stimulation NCT07371676 · Effects of Vagus Nerve Stimulation on the Autonomic Nervous System | Sclérose en plaques | Traitement symptomatique | Non applicable | COMPLETED | The aim of this study is to determine the effect of vagus nerve stimulatio… À vérifier | ClinicalTrials.gov 2026-08-26 14:49:11 | Détail |
| Transauricular vagus nerve stimulation (taVNS) NCT05801809 · Understanding the Effects of Transauricular Vagus Nerve Stimulation on Neural Ne… | Sclérose en plaques | À vérifier | Non applicable | COMPLETED | This trial aims to perform an exploratory, mechanistic, randomized double-… À vérifier | ClinicalTrials.gov 2026-08-26 14:49:11 | Détail |
| transcutaneous vagus nerve stimulation NCT03553485 · Effects of VNS on RT-induced Inflammation and Prognosis of Patients With NSCLC | Sclérose en plaques | Immunomodulation | Non applicable | UNKNOWN | Attaining goals or rewards commonly entails response costs. In light of co… À vérifier | ClinicalTrials.gov 2026-08-26 14:49:11 | Détail |
| Transcutaneous Vagus Nerve Stimulation Paired with Tailor-Made Notche… NCT05417711 · Efficacy of Transcutaneous Vagus Nerve Stimulation Paired With Tailor-Made Notch… | Sclérose en plaques | À vérifier | Non applicable | NOT_YET_RECRUITING | This clinical study is a prospective, multicenter, randomized, controlled,… À vérifier | ClinicalTrials.gov 2026-08-26 14:49:11 | Détail |
| Vagus nerve stimulation NCT06923007 · Advant — Alzheimer's Disease Treated With Vagus Nerve Stimulation | Sclérose en plaques | À vérifier | Non applicable | RECRUITING | Vagus nerve stimulation is thought to reduce sympathetic nerve outflow and… À vérifier | ClinicalTrials.gov 2026-08-26 14:49:11 | Détail |
| Aerobic Exercise for Remyelination in Multiple Sclerosis NCT04539002 · NCT04539002 | Sclérose en plaques | Remyélinisation | Phase 1/2 | COMPLETED | This is a clinical trial to determine the feasibility of a stationary aero… À vérifier | ClinicalTrials.gov 2026-08-26 14:49:08 | Détail |
| AMIS — Serum Neurofilaments and GFAP in Atypical Multiple Sclerosis NCT04201470 · NCT04201470 | Sclérose en plaques | Remyélinisation · Immunomodulation | Non applicable | COMPLETED | Idiopathic inflammatory disorders of the central nervous system include va… À vérifier | ClinicalTrials.gov 2026-08-26 14:49:08 | Détail |
| Clemastine Fumarate NCT06065670 · ReINFORCE — Assessing Changes in Multi-parametric MRI in Patients With Acute Dem… | Sclérose en plaques | Remyélinisation · Immunomodulation | Phase 1/2 | NOT_YET_RECRUITING | The clinical trial is intended to assess for clinical evidence of Clemasti… À vérifier | ClinicalTrials.gov 2026-08-26 14:49:08 | Détail |
| CT103A NCT04561557 · CARTinNS — Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-… | Sclérose en plaques | Remyélinisation · Immunomodulation · Thérapie cellulaire | Phase 1 | RECRUITING | Antibody-mediated inflammatory diseases of the nervous system (also known… À vérifier | ClinicalTrials.gov NCT04561557 ; Cell 2025 (Qin et al.… 2026-08-26 14:49:08 | Détail |
| Intravenous steroid NCT05154370 · CNRID — China National Registry of Neuro-Inflammatory Diseases | Sclérose en plaques | Remyélinisation · Ralentissement de la progression · Immunomodulation | À vérifier | RECRUITING | Central nervous system (CNS) idiopathic inflammatory demyelinating disease… À vérifier | ClinicalTrials.gov 2026-08-26 14:49:08 | Détail |
| MOGHEAD — Headache Prevalence and Phenotype in Myelin Oligodendrocyte… NCT07479212 · NCT07479212 | Sclérose en plaques | Remyélinisation · Immunomodulation · Traitement symptomatique | À vérifier | NOT_YET_RECRUITING | Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) is… À vérifier | ClinicalTrials.gov 2026-08-26 14:49:08 | Détail |
| Oligodendrocyte progenitor cell culture/craniotomy NCT00283023 · Oligodendrocyte Progenitor Cell Culture From Human Brain | Sclérose en plaques | Remyélinisation | Phase 1 | COMPLETED | Recent developments in the understanding of stem- and progenitor cell diff… À vérifier | ClinicalTrials.gov 2026-08-26 14:49:08 | Détail |
| PET-MRI with [18F]-Florbetaben and PET-MRI with [18F]-DPA-714 NCT05147532 · SMARTinMS — Remyelination in Multiple Sclerosis: a PET-MR Longitudinal Study Inv… | Sclérose en plaques | Remyélinisation · Immunomodulation | Non applicable | UNKNOWN | Multiple Sclerosis (MS) is an inflammatory disease where the immune cells… À vérifier | ClinicalTrials.gov 2026-08-26 14:49:08 | Détail |
| RECLAIM — Clinical Impact Through AI-assisted MS Care - A Retrospecti… NCT06280755 · NCT06280755 | Sclérose en plaques | Ralentissement de la progression | À vérifier | RECRUITING | The RECLAIM study aims to gather a centralized and harmonized dataset, ena… À vérifier | ClinicalTrials.gov 2026-08-26 14:49:08 | Détail |
| rhIGF-1 (CEP-151) NCT00001669 · A 48-Week (24-Week Baseline Followed by a 24-Week Treatment) Phase II Pilot Stud… | Sclérose en plaques | Remyélinisation | Phase 2 | COMPLETED | The drug rhIGF-1 (CEP-151) has been shown to play a key role preclinically… À vérifier | ClinicalTrials.gov 2026-08-26 14:49:08 | Détail |
| The Effect of Telerehabilitation Based Pilates Training in Multiple S… NCT04838886 · NCT04838886 | Sclérose en plaques | Remyélinisation · Immunomodulation · Traitement symptomatique · Thérapie génique | Non applicable | COMPLETED | Multiple Sclerosis (MS) is a chronic inflammatory disease of the central n… À vérifier | ClinicalTrials.gov 2026-08-26 14:49:08 | Détail |
| Clemastine Fumarate NCT05338450 · RESTORE — Clemastine Fumarate as Remyelinating Treatment in Internuclear Ophthal… | Sclérose en plaques | Remyélinisation · Immunomodulation | Phase 3 | TERMINATED | The clinical trial is intended to assess for clinical evidence of Clemasti… À vérifier | ClinicalTrials.gov 2026-08-26 14:49:07 | Détail |
Découverte scientifique
Recherches et trouvailles 21
Projets précliniques, publications émergentes et programmes de recherche suivis dans le pipeline.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| 4-octyl itaconate et dérivés Dérivés de l’itaconate — neuroinflammation | Sclérose latérale amyotrophique | Neuroprotection · Immunomodulation | Découverte fondamentale | Exploratoire | Modulation immunométabolique de la microglie · NRF2 / inflammation microgl… Piste mécanistique visant à reprogrammer la réponse inflammatoire de la microglie. Le lien avec la SLA reste exploratoi… | Revue scientifique 2024-07-01 | Détail |
Bibliographie
Publications 4910
Références bibliographiques de la base locale et accès à leur source originale.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| A comparative study of the role of crocin and sitagliptin in attenuat… Standard Oral Hypoglycemic Agent · PMID 31394428 | Maladie rénale chronique | Ralentissement de la progression · Immunomodulation | Publication | PubMed | Voir la publication source Type 1 diabetes mellitus (T1DM) describes a complex group of metabolic disorders associated with elevated blood glucose… | Environmental toxicology and pharmacology 2026-11-15 04:38:02 | Source |
| Anti diabetic effect of Achyranthes rubrofusca leaf extracts on allox… Standard Oral Hypoglycemic Agent · PMID 21454169 | Maladie rénale chronique | À vérifier | Publication | PubMed | Voir la publication source The aqueous and ethanolic extracts of Achyranthes rubrofuca leaves (AR) were studied for their hypoglycemic activity. T… | Pakistan journal of pharmaceutical sciences 2026-11-15 04:38:02 | Source |
| Antihyperglycemic and hypolipidemic activities of Setaria italica see… Standard Oral Hypoglycemic Agent · PMID 20869855 | Maladie rénale chronique | À vérifier | Publication | PubMed | Voir la publication source Setaria italica is commonly known as Foxtail millet. In India it is chiefly cultivated in Andhra Pradesh and Tamilnadu.… | Pathophysiology : the official journal of the Internat… 2026-11-15 04:38:02 | Source |
| Enhancing neoadjuvant immunotherapy for locally advanced rectal cance… HJB647 high dose · PMID 42860120 | Cancer | Immunomodulation | Publication | PubMed | Voir la publication source Conventional surgery for locally advanced rectal cancer (LARC) faces challenges including difficult sphincter preservat… | Biomaterials 2026-11-15 04:37:50 | Source |
| Oxygen-vacancy-rich LDH sonosensitizers potentiate narrow-spectrum an… HJB647 high dose · PMID 42910182 | Insuffisance cardiaque | Neuroprotection · Immunomodulation · Thérapie génique | Publication | PubMed | Voir la publication source Mixed bacterial infections, including Gram-positive and Gram-negative pathogens, remain a major global health concern.… | Bioactive materials 2026-11-15 04:37:50 | Source |
| Respiratory Support With Nasal High Flow Reduces Opioid Requirements… HJB647 high dose · PMID 42699223 | Insuffisance cardiaque | À vérifier | Publication | PubMed | Voir la publication source Nasal high flow (NHF) improves oxygenation, reduces the work of breathing, and stabilizes ventilation. In endoscopic re… | DEN open 2026-11-15 04:37:50 | Source |
| Feasibility of a Deep-Learning Model for Objective Visualization-Qual… Lithotripsy · PMID 42898633 | Maladie coronarienne | À vérifier | Publication | PubMed | Voir la publication source During peroral cholangioscopy-guided electrohydraulic lithotripsy (EHL), stone fragmentation obscures the visual field… | DEN open 2026-11-15 04:37:45 | Source |
| Impact of calcium burden, lesion preparation, and lithotripsy on sten… Lithotripsy · PMID 42777787 | Maladie coronarienne | À vérifier | Publication | PubMed | Voir la publication source Stent underexpansion in severely calcified coronary lesions increases the risk of target vessel failure. Intravascular… | International journal of cardiology 2026-11-15 04:37:45 | Source |
| Intravascular lithotripsy for calcific stenosis of the abdominal aort… Lithotripsy · PMID 43001236 | Maladie coronarienne | À vérifier | Publication | PubMed | Voir la publication source Takayasu arteritis is a rare large-vessel vasculitis that predominantly affects the aorta and its major branches. Altho… | Journal of vascular surgery cases and innovative techn… 2026-11-15 04:37:45 | Source |
| Placenta-derived mesenchymal stem cells for prenatal myelomeningocele… cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells · PMID 42… | Sclérose en plaques · Sclérose latérale amyotrophique · Sclérose laté… | Thérapie cellulaire | Publication | PubMed | Voir la publication source Résumé non disponible dans la base locale. | Annals of translational medicine 2026-11-15 04:37:41 | Source |
| Synovial Biomarker Modulation and Clinical Response to Umbilical Cord… cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells · PMID 42… | Sclérose en plaques · Sclérose latérale amyotrophique · Sclérose laté… | Immunomodulation · Thérapie cellulaire | Publication | PubMed | Voir la publication source ObjectiveUmbilical cord-derived mesenchymal stromal cells (UC-MSCs) are a promising treatment for knee osteoarthritis (… | Cartilage 2026-11-15 04:37:41 | Source |
| Design, synthesis, and biological evaluation of 1H-1,2,4-triazole-3-c… B007 · PMID 42142713 | Insuffisance cardiaque | À vérifier | Publication | PubMed | Voir la publication source The apelin receptor (AplnR) is a prominent peptide-binding Class A G protein-coupled receptor (GPCR) involved in the re… | Bioorganic & medicinal chemistry letters 2026-11-15 04:37:34 | Source |
| Programmable Nanobody-Targeting Chimeras Enable Intracellular Viral P… B007 · PMID 42467897 | Myasthénie | À vérifier | Publication | PubMed | Voir la publication source Chronic hepatitis B virus (HBV) infection remains a major global health challenge, largely because current antiviral th… | Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2026-11-15 04:37:34 | Source |
| Understanding the Selectivity of Selective Oxidation of Propane to Ac… B007 · PMID 41768713 | Myasthénie | À vérifier | Publication | PubMed | Voir la publication source In this work, we have performed a quantum chemical investigation for the selective oxidation of propane toward acrylic… | ACS omega 2026-11-15 04:37:34 | Source |
| Comparative efficacy and acceptability of antidepressants in the long… Milnacipran · PMID 43008763 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source Major depressive disorder carries high risks of relapse and chronicity, necessitating treatments that achieve and maint… | The lancet. Psychiatry 2026-11-15 04:37:30 | Source |
| Polysubstance-Induced Vasoplegia Managed with Venoarterial Extracorpo… Milnacipran · PMID 43014364 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source While the use of venoarterial extracorporeal membrane oxygenation (VA-ECMO) becomes increasingly commonplace in overdos… | Clinical practice and cases in emergency medicine 2026-11-15 04:37:30 | Source |
| Early Outcome of a Single Peri-Tendinous Hyaluronic Acid Injection fo… Sodium hyaluronate with mannitol (Ostenil Tendon) · PMID 33132010 | Myopathies | Traitement symptomatique | Publication | PubMed | Voir la publication source The aim of this study was to evaluate the efficacy and safety of a single, peri-tendinous injection of hyaluronic acid… | Foot (Edinburgh, Scotland) 2026-11-15 04:37:29 | Source |
| Engineered stem cell-derived CD16-enhanced universal NKT cells improv… Tafasitamab and NK cells · PMID 43008138 | Cancer | Immunomodulation · Thérapie cellulaire | Publication | PubMed | Voir la publication source Monoclonal antibody (mAb)-based therapies have revolutionized cancer treatment; however, their clinical efficacy is oft… | Cancer immunology research 2026-11-15 04:37:24 | Source |
| Precision Fc remodeling via glycosylation-competent CHO display enabl… Tafasitamab and NK cells · PMID 41923108 | Cancer | Immunomodulation | Publication | PubMed | Voir la publication source BACKGROUND: Improving tumor cell clearance by therapeutic antibodies remains a translational bottleneck because wild-ty… | Journal of biological engineering 2026-11-15 04:37:24 | Source |
| The Fc-engineered CD19 antibody MOR208 (XmAb5574) induces natural kil… Tafasitamab and NK cells · PMID 23277329 | Lupus | À vérifier | Publication | PubMed | Voir la publication source Résumé non disponible dans la base locale. | Leukemia 2026-11-15 04:37:24 | Source |
Exploration — prudence
Pistes exploratoires 0
Rapprochements mécanistiques et hypothèses de recherche : ils ne constituent pas une preuve d’efficacité ni une recommandation thérapeutique.
Hypothèses non validéesÀ confirmer par des travaux précliniques, cliniques et une revue scientifique indépendante.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Aucune piste exploratoire ne correspond aux filtres. | |||||||